MedTrace Logo

Effect of Azithromycin on Fatty Acids in CF

NCT03045198 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-08-02

No results posted yet for this study

Summary

In collaboration with Dr.Birgit Alteheld, Institute of Nutrional Sciences of the university of Bonn, Germany the following effect is explored: Effect of a 4 week therapy with AZT on synthesis of lipoproteins as well as Docosahexaen and other fatty acids in patients with Cystic Fibrosis (CF). Moreover proinflammatory cytokines in blood and sputum are of interest.

Conditions

Interventions

DRUG

Azithromycin

Sponsors & Collaborators

  • University of Bonn

    collaborator OTHER

  • Goethe University

    collaborator OTHER

  • University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn)

    lead OTHER

Principal Investigators

  • Sabina Schmitt-Grohé, MD · University Children's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03045198 on ClinicalTrials.gov